QUANTUMPH-P (02228) issued 8.796 million shares based on partial exercise of the excess rights issue.

ZHITONGCAIJING APP news, QUANTUMPH-P (02228) announced that on July 10, 2024, 8.796 million ordinary shares were issued and distributed based on the partial exercise of the over-allotment option.

Zhitong FinanceJul 10 07:41 ET

QUANTUM PH-P (02228.HK): Partial exercise of the over-allotment option, involving a total of 8.796 million shares.

On July 7th, Guolong reported that QUANTUM PH-P (02228.HK) announced that the oversubscription rights described in the prospectus have been partially exercised by the joint coordinators (on behalf of the company and the international underwriters) and involve a total of 8.796 million shares, equivalent to approximately 4.69% of the total number of sale shares preliminarily available for subscription under the global offering before any oversubscription rights were exercised. The excess shares will be issued by the company at a price of HKD 5.28 per share. The excess shares will be used to encourage Citic Lyon Securities (Stabilization Merchant) to subscribe to QuantumPharm.

Gelonghui FinanceJul 7 07:53 ET

QUANTUMPH-P(02228): Partial exercise of the over-allotment option, price stabilization action and stabilization period ended.

Wisdom Financial app news: QUANTUMPH-P (02228) announced that the over-allotment rights mentioned in the prospectus have been partially exercised by the joint coordinators (including themselves and the representatives of international underwriters) on Sunday, July 7, 2024. The total number of shares involved is 8.796 million shares, which is equivalent to about 4.69% of the initial shares available for subscription under the global offering before the exercise of any over-allotment rights. The over-allotment shares will be issued by the company at HKD 5.28 per share. The proceeds from the exercise of the over-allotment shares will be used to promote Citic Lyon Securities Limited (Stable Market Maker) to Quantum Ph.

Zhitong FinanceJul 7 07:41 ET

[IPO Monthly Report] The Hong Kong IPO market saw a surge in subscription popularity and a significant decrease in the rate of IPOs breaking below the issue price in June. The expectations of the "Big Four" were mixed with both sorrow and joy.

In the first half of 2024, Hong Kong's IPO market continued its recent sluggish trend due to external market factors, global economic uncertainty, and cautious investor sentiment. The "Big Four" lowered their forecast for Hong Kong's annual IPO fundraising at the beginning of the year, but PwC expects Hong Kong's new IPO fundraising to exceed HKD 100 billion this year. PwC stated that the reduction in bearish factors, high demand for funding for business development, and the end of the interest rate hike cycle will bring back funds from Europe, America, and the Middle East to Asia, which is beneficial for market liquidity and valuation improvement. After six months of market baptism, PwC finally gave in and lowered Hong Kong's...

金吾財訊Jul 3 05:07 ET

Express News | Shares of AI Drug Researcher Quantumpharm Inc Jump More Than 10% on Hong Kong Debut

ReutersJun 12 21:47 ET

Express News | Tencent-Backed Quantumpharm Inc Set to Open up 2% in Hong Kong Debut

ReutersJun 12 21:25 ET